Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / CD Molecules

Recombinant Human CD39/ENTPD1 Protein, N-His

Catalog #:   YHE74001 Specific References (50) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: P49961
Protein length: Met1-Tyr340
Overview

Catalog No.

YHE74001

Expression system

E. coli

Species

Homo sapiens (Human)

Protein length

Met1-Tyr340

Predicted molecular weight

40.86 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

P49961

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

Ecto-ATP diphosphohydrolase 1, NTPDase 1, ENTPD1, Ecto-ATPase 1, Ecto-apyrase, Ecto-ATPDase 1, Ectonucleoside triphosphate diphosphohydrolase 1, CD39, Lymphoid cell activation antigen

Data Image
  • SDS-PAGE
    SDS PAGE for recombinant Human CD39/ENTPD1
References

Genetically predicted immune cells mediates the association between hepatocellular carcinoma and inflammatory proteins: a Mendelian randomization study., PMID:40504445

Expression of the Transcription Factor FOXP3 in Human Peripheral Blood B-Cell Subtypes (CD19+CD39+ and CD19+CD39-) and Evaluation of Their Regulatory Function., PMID:40497715

Increase of CD4+CD25+FoxP3+Regulatory T Cells in Myeloma., PMID:40497604

Immunoinflammatory evidence of rheumatoid arthritis caused by COVID-19., PMID:40495223

CD39-Diannexin alleviates the platelet storage lesion by protecting platelets from activation, a new attempt from a traditional perspective., PMID:40491155

Targeting CD39 boosts PD-1 blockade antitumor therapeutic efficacy via strengthening CD8 + TILs function and recruiting B cells in cervical cancer., PMID:40462160

Compromised adenosine-A2AR axis contributes to recurrent spontaneous abortion by promoting proinflammatory macrophage polarization., PMID:40373597

Characterization of the aryl hydrocarbon receptor as a potential candidate to improve cancer T cell therapies., PMID:40358739

Adenosine signaling in promoting the balance between erythropoiesis and myelopoiesis., PMID:40314242

Deconvoluting TCR-dependent and -independent activation is vital for reliable Ag-specific CD4+ T cell characterization by AIM assay., PMID:40279430

Regulatory T Cell Mimicry by a Subset of Mesenchymal GBM Stem Cells Suppresses CD4 and CD8 Cells., PMID:40277917

Expression of the TIGIT axis and the CD39/CD73 purinergic pathway in bone metastasis-derived immune cells., PMID:40274631

Immune-activated microspheres for enhanced chemoembolization of hepatocellular carcinoma by blocking the adenosine A2A receptor., PMID:40274057

PD1+ T Regulatory Cells Are Not Sufficient to Protect from Gestational Hypertension., PMID:40243452

Flow Cytometric Analysis of Mouse Brain CD8+ T Cell Activation., PMID:40220234

CD40L stimulates tumor-infiltrating B-cells and improves ex vivo TIL expansion., PMID:40199608

Adenosine-generating CD39+ plasmablasts predispose to successful infliximab therapy in pediatric IBD., PMID:40199584

Jatrorrhizine alleviates cytokine storm secondary lung injury via regulating CD39-dominant purinergic braking and downstream NLRP3 inflammasome., PMID:40192171

TGF-β Induces the Secretion of Extracellular Vesicles Enriched with CD39 and CD73 from Cervical Cancer Cells., PMID:40141056

Bacterial vaginosis associates with dysfunctional T cells and altered soluble immune factors in the cervicovaginal tract., PMID:40131862

Decreased circulating CD39+ regulatory T cell frequencies following non-traumatic brain death., PMID:40118258

Low levels of CD39+ Tregs may predict poor outcome in children with sepsis., PMID:40117807

Dysregulation of γδ intraepithelial lymphocytes precedes Crohn's disease-like ileitis., PMID:40117343

CD73: a new immune checkpoint for leukemia treatment., PMID:40114928

mTOR Inhibition limits LPS induced acute kidney injury and ameliorates hallmarks of cellular senescence., PMID:40113898

The effects of nanocurcumin on immune-related factors in the ankylosing spondylitis patients: a double-blind, randomized, placebo-controlled clinical trial., PMID:40106064

Impact of Estrogen on Purinergic Signaling in Microvascular Disease., PMID:40076726

CD39 Contributes to the Ability of Cell Invasion in Heterogeneity of Colorectal Cancer., PMID:40052646

Knowledge about globin genetics for precision diagnosis of hemoglobinopathies: A case Study., PMID:40023305

Causal Association Between Inflammatory Proteins, Inflammatory Cells, and Cauda Equina Syndrome: A Two-Sample Mendelian Randomization., PMID:40020998

Relationship between purinergic signalling and oxidative stress in prostate cancer: Perspectives for future therapy., PMID:40015351

Predictive circulating biomarkers of the response to anti-PD-1 immunotherapy in advanced HER2 negative breast cancer., PMID:40000397

The CD39/CD73/Adenosine and NAD/CD38/CD203a/CD73 Axis in Cutaneous T-Cell Lymphomas., PMID:39996780

Adenosine metabolism and receptors in aging of the skin, musculoskeletal, immune and cardiovascular systems., PMID:39971100

Treg fitness signatures as a biomarker for disease activity in Juvenile Idiopathic Arthritis., PMID:39954509

Transvitreal Retinochoroidal Biopsies of Primary Uveal Melanoma Reveal an Association of Low HLA Class I and High NK Cell Abundance in Low-Risk Disease., PMID:39918475

Regulatory T cells converted from Th1 cells in tumors suppress cancer immunity via CD39., PMID:39907686

CD73 promotes the maturation of murine NK cells and their survival in the tumor microenvironment., PMID:39901844

Noncanonical NF-κB signaling in dendritic cells is required for ATP-driven indoleamine 2,3-dioxygenase 1 induction through P2Y11 receptor., PMID:39899472

T Cell-Derived Apoptotic Extracellular Vesicles Ameliorate Bone Loss via CD39 and CD73-Mediated ATP Hydrolysis., PMID:39895982

Recirculating regulatory T cells mediate thymic regeneration through amphiregulin following damage., PMID:39892391

Blocking the CD39/CD73 pathway synergizes with anti-CD20 bispecific antibody in nodal B-cell lymphoma., PMID:39884778

Reduced autoimmunity associated with deletion of host CD73., PMID:39846845

Microglia modulate the cerebrovascular reactivity through ectonucleotidase CD39., PMID:39843911

OMIP-110: A 37-Color Spectral Flow Cytometric Panel to Assess Transcription Factors and Chemokine Receptors in Human Intestinal Lymphoid Cells., PMID:39838760

Identification of B Cell Subpopulations with Pro- and Anti-Tumorigenic Properties in an Immunocompetent Mouse Model of Head and Neck Squamous Cell Carcinoma., PMID:39791721

Elucidating the molecular association and potential mechanisms between psoriasis and atrial fibrillation through biomarker and immune infiltration analysis., PMID:39776247

Characterization of the adaptive immune response in a mouse model for HPV-positive head and neck squamous cell carcinoma with implications to human disease., PMID:39751916

Reduced number of regulatory T cells in maternal circulation precede idiopathic spontaneous preterm labor in a subset of patients., PMID:39743391

Assessment of adenosinergic activity of small extracellular vesicles in plasma of cancer patients and healthy donors., PMID:39704041

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human CD39/ENTPD1 Protein, N-His [YHE74001]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only